FDA To Virtually Convene Orthopedic Panel
The meeting was originally scheduled to meet in-person in April
Executive Summary
In a sign the US FDA is trying to address key issues not related to COVID-19, the agency is bringing together an expert panel almost five months after it was originally slated to meet to discuss classifying a slew of orthopedic devices.